Header Logo

Connection

Alan Landay to HIV Envelope Protein gp120

This is a "connection" page, showing publications Alan Landay has written about HIV Envelope Protein gp120.
Connection Strength

0.081
  1. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science. 2004 Jan 16; 303(5656):316.
    View in: PubMed
    Score: 0.057
  2. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol. 2006 Nov; 48(2):267-73.
    View in: PubMed
    Score: 0.017
  3. Complement activation by human monoclonal antibodies to human immunodeficiency virus. J Virol. 1993 Jan; 67(1):53-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.